Morgan, G. (2012) Myeloma: diagnosis complications and supportive care. HEMATOLOGY, 17. S109-S111. ISSN 0361-8609

Full text not available from this repository.

Abstract

A key approach to current treatment is the rapid reduction of the myeloma clone to minimal disease levels. This approach has significantly improved outcomes but it remains critical to manage the side effects of the disease and of treatment emergent side effects. While these supportive care options are directed towards improving patient quality of life, they also have significant effect against the disease and can improve survival.

Item Type:	Article
Authors (ICR Faculty only):	Morgan, Gareth
All Authors:	Morgan, G.
Additional Information:	ISI Document Delivery No.: 927OA Times Cited: 0 Cited Reference Count: 15 Morgan, Gareth Maney publishing Leeds 1
Uncontrolled Keywords:	Multiple myeloma Supportive care Bone disease Anaemia Thrombosis Zometa randomized controlled-trial multiple-myeloma zoledronic acid clodronic acid guidelines management ix
Research teams:	ICR divisions > Clinical Studies > Molecular Haematology (including Cytogenetics Group and Cell Markers) ICR divisions > Molecular Pathology > Molecular Haematology (including Cytogenetics Group and Cell Markers)
Depositing User:	Barry Jenkins
Date Deposited:	14 May 2012 14:27
Last Modified:	14 May 2012 14:27
URI:	http://publications.icr.ac.uk/id/eprint/11625

Actions (login required)

View Item